' Dramatic ' Inflammation Reduction After OHCA With Tocilizumab ' Dramatic ' Inflammation Reduction After OHCA With Tocilizumab

A pilot study showed reduced systemic inflammatory response and cardiac injury in out-of-hospital cardiac arrest patients, with the hope of affecting mortality and neurologic outcome in larger trials.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Cardiology News Source Type: news